Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.4 GBX
Market Closed
Updated:
May 14, 2024
Fusion Antibodies PLC
Common Stock
|
Fusion Antibodies PLC
Common Stock Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Common Stock
£2.4m
|
CAGR 3-Years
33%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Common Stock
£86k
|
CAGR 3-Years
34%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Common Stock
£671k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Common Stock
£169k
|
CAGR 3-Years
7%
|
CAGR 5-Years
281%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Common Stock
£508k
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Common Stock
£680k
|
CAGR 3-Years
-2%
|
CAGR 5-Years
35%
|
CAGR 10-Years
21%
|
See Also
What is Fusion Antibodies PLC's Common Stock?
Common Stock
2.4m
GBP
2.4m
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Common Stock amounts to 2.4m GBP.
What is Fusion Antibodies PLC's Common Stock growth rate?
Common Stock CAGR 5Y
22%
22%
Over the last year, the Common Stock growth was 129%. The average annual Common Stock growth rates for Fusion Antibodies PLC have been 33% over the past three years , 22% over the past five years .
You don't have any saved screeners yet
